Form 4: Veru CFO Michele Greco Receives Stock Option Grant

Veru Inc. Chief Administrative Officer and CFO Michele Greco was granted 164,000 stock options with an exercise price of $2.25.

Summary

• Michele Greco, Chief Administrative Officer and CFO of Veru Inc., was granted 164,000 stock options on May 4, 2026.
• The options have an exercise price of $2.25 per share.
• The options vest in three equal annual installments starting May 4, 2027, with full vesting by May 4, 2029.
• The options expire on May 4, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative disclosure regarding routine executive compensation.

Positives

• Aligns executive compensation with long-term shareholder interests through a multi-year vesting schedule.

Negatives

• Results in potential future dilution for existing shareholders upon the exercise of these options.

Risks

• Market price volatility could impact the value of the options and the incentive structure for the executive.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a standard disclosure of executive equity compensation.

Industry Context

StockSavvy.ai notes that equity-based compensation for C-suite executives is a standard practice in the biotechnology and pharmaceutical sectors to retain talent and align management with long-term corporate performance.

Comparison to Industry Standards

• The three-year vesting schedule is consistent with standard corporate governance practices for executive equity grants.
• The use of stock options as a primary incentive tool is common among mid-cap and small-cap biotech firms.

Stakeholder Impact

• Shareholders may experience minor dilution if these options are exercised in the future.

Next Steps

• Vesting of the first tranche of options on May 4, 2027.

Key Dates

Keywords

Veru Inc, VERU, SEC Form 4, Insider Trading, Stock Options, Executive Compensation, CFO